...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Private placement??

TAda,

Hopefully management is working on something more important down at RVX headquarters that is the reason for the delay...

Share
New Message
Please login to post a reply